Abstract: Powered by advances of optical remote sensing sensors, the production of very high spatial-resolution multispectral images provides great potential for achieving cost-efficient and ...
Recursion Pharmaceuticals (RXRX) is upgraded to Buy, driven by promising REC-4881 data and analyst optimism for FAP market potential. REC-4881's Phase 1b/2 results show a 43% median polyp burden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback